Last updated on June 2019

Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)- Measure Up 1

Brief description of study

The objective of this study is to assess the efficacy and safety of upadacitinib for the treatment of adolescent and adult participants with moderate to severe Atopic Dermatitis (AD) who are candidates for systemic therapy.

Clinical Study Identifier: NCT03569293

Find a site near you

Start Over

Investigate MD /ID# 201256

Scottsdale, AZ United States
  Connect »

Tien Q Nguyen MD, Inc /ID# 201910

Fountain Valley, CA United States
  Connect »

UC Davis /ID# 203622

Sacramento, CA United States
  Connect »

Synergy Dermatology /ID# 200842

San Francisco, CA United States
  Connect »

Care Access Research /ID# 200940

Walnut Creek, CA United States
  Connect »

Sullivan Dermatology /ID# 200671

North Miami Beach, FL United States
  Connect »

Dawes Fretzin, LLC /ID# 200366

Indianapolis, IN United States
  Connect »

Cleaver Dermatology /ID# 202825

Kirksville, MO United States
  Connect »

Newton Clinical Research /ID# 204169

Oklahoma City, OK United States
  Connect »

Alison Ehrlich LLC /ID# 213682

Washington, WA United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.